Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

House Passes Drug Pricing Bill, Likely Ending its Journey

Key clinical point: The House passed H.R. 3, a bill aimed at lowering the cost of prescription pharmaceuticals.

Major finding: H.R. 3 passed 230-192 in a near party-line vote.

Study details: It is unlikely that the bill will advance further in the legislative process as it faces opposition in both the Republican-controlled Senate and the White House.

Disclosures: The House, as the voting body, makes no disclosures about this bill.

Citation:

U.S. House of Representatives